Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Summary

Current therapies for Stage IV non-small cell lung cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV lung cancer PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV lung cancer.

Timeline

Start

1996-08-21

Primary completion

1998-02-02

Completion

1998-02-02

Drugs

Indications